100% tevredenheidsgarantie Direct beschikbaar na je betaling Lees online óf als PDF Geen vaste maandelijkse kosten 4.2 TrustPilot
logo-home
Tentamen (uitwerkingen)

NURS 8022 EXAM 1 2024/2025 Detailed with complete Questions and Answers

Beoordeling
-
Verkocht
-
Pagina's
44
Cijfer
A+
Geüpload op
25-09-2024
Geschreven in
2024/2025

NURS 8022 EXAM 1 2024/2025 Detailed wHematopoiesis - CORRECT ANSWER - Process of blood cell production in adult bone marrow or the liver and/or spleen of the fetus Two stages ▪ Mitosis (proliferation) ▪ Maturation (differentiation) Primary site of hematopoietic stem cells - CORRECT ANSWER - Bone marrow ("myeloid tissue") Difference between red and yellow bone marrow - CORRECT ANSWER - Red marrow produces RBCs, yellow marrow does not produce RBCs Active bone marrow sites - CORRECT ANSWER - pelvic bones vertebrae cranium mandible sternum ribs humerus femur Factors that increase hematopoiesis - CORRECT ANSWER - (1) conversion of yellow bone marrow, which does not produce blood cells, to hematopoietic red marrow by the actions of erythropoietin (a hormone that stimulates erythrocyte production) (2) faster differentiation of progenitor cells (3) faster proliferation of stem cells into progenitor cells Erythropoiesis - CORRECT ANSWER - production of RBCs ith complete Questions and Answers

Meer zien Lees minder
Instelling
Vak











Oeps! We kunnen je document nu niet laden. Probeer het nog eens of neem contact op met support.

Geschreven voor

Instelling
Vak

Documentinformatie

Geüpload op
25 september 2024
Aantal pagina's
44
Geschreven in
2024/2025
Type
Tentamen (uitwerkingen)
Bevat
Vragen en antwoorden

Onderwerpen

Voorbeeld van de inhoud

NURS 8022 EXAM 2 2024/2025
(Detailed with complete Questions and Answers)


VERIFIED
Hematopoiesis - CORRECT ANSWER - Process of blood cell production in
adult bone marrow or the liver and/or spleen of the fetus


Two stages
▪ Mitosis (proliferation)
▪ Maturation (differentiation)
Primary site of hematopoietic stem cells - CORRECT ANSWER - Bone marrow
("myeloid tissue")
Difference between red and yellow bone marrow - CORRECT ANSWER - Red
marrow produces RBCs, yellow marrow does not produce RBCs
Active bone marrow sites - CORRECT ANSWER - pelvic bones
vertebrae
cranium
mandible
sternum
ribs
humerus
femur
Factors that increase hematopoiesis - CORRECT ANSWER - (1) conversion of
yellow bone marrow, which does not produce blood cells, to hematopoietic red
marrow by the actions of erythropoietin (a hormone that stimulates erythrocyte
production)
(2) faster differentiation of progenitor cells
(3) faster proliferation of stem cells into progenitor cells
Erythropoiesis - CORRECT ANSWER - production of RBCs

,Sequence of erythropoiesis - CORRECT ANSWER - Pluripotent hematopoietic
stem cell --> committed Proerythroblast/Pronormoblast -->
Erythroblast/Normoblast (Hgb synthesis begins) --> Reticulocyte (nucleus is
lost; 3 days spent in bone marrow, about 1 day in blood) --> Erythrocyte


** aprox. 1% of RBCs are reticulocytes **


In each step the quantity of hemoglobin increases and the nucleus decreases in
size
Erythropoietin - CORRECT ANSWER - A hormone produced and released by
the kidney that stimulates the production of red blood cells by the bone marrow


Always present in plasma


Released in response to low renal oxygenation
- NOT the # of RBCs but rather oxygen delivery
- e RBC production increases within 24 hours; life span 4-12 hours; increased
RBC # in 5 days
- Given to dialysis and chemo patients
Reticulocytes - CORRECT ANSWER - ▪ Last immature form of erythroblast


▪ Contains polyribosomes (globin synthesis) and mitochondria (heme synthesis)


▪ 24-48 hours after leaving bone marrow for circulation, matures into erythrocyte
- Loses polyribosomes and mitochondria
-Make up 1-2% of RBCs
- Last about 2 days in bone marrow and 1 day in blood continuing to mature
- During time of low HCT time in marrow decreased to as little as 1 day


▪ Reticulocyte count -- Indicates whether new RBCs are being produced; good
indicator of erythropoiesis

,Renal oxygenation negative feedback loop - CORRECT ANSWER -
Hemoglobin and its structure - CORRECT ANSWER - Oxygen-carrying
protein of the erythrocyte --> may carry up to 300 hgb molecules


Reversible deformity to be abvle to squeeze through the tiniest of capillaries


Each Hgb molecule has 2 pairs of different globin chains and 4 complexes of
iron + heme
▪ Heme: large, flat, iron-protoporphyrin disk that is synthesized in the
mitochondria and can carry one molecule of oxygen
▪ Each Hgb can carry 4 molecules of oxygen
Heme vs Globin - CORRECT ANSWER - Heme: Synthesized in mitochondria of
reticulocyte
- Carries Oxygen


Globin: Polyribosomes in reticulocytes
- 2 pairs of globin chains on each Hgb molecule
- Combo of pair determines type of globin chain
▪ Most common hgb A: 2 alpha chains and 2 beta chains - hgb F (fetal): 2 alpha, 2
gamma
Red blood cell structure - CORRECT ANSWER - Sac of Hgb, no nucleus or
mitochondria, only hemoglobin & enzymes surrounded by membrane


-Lack mitochondria, rely on glycolysis for energy --> "aerobic metabolism"


▪ Deficiencies of 2 enzymes result in anemia
• Pyruvate kinase - necessary for glycolysis - no glycolysis results in RBC
damage and death
• G6PD - involved in protecting the RBC against oxidative stress
Anisocytosis
Poikilocytosis - CORRECT ANSWER - Variation in RBC size

, Variation in RBC shape
Hereditary vs Acquired Hemolysis - CORRECT ANSWER - Hereditary
hemolysis: sickle cell disease


Acquired hemolysis: immune mechanisms (transfusion reaction), infection
(malaria), drugs (penicillin), liver or kidney disease, toxins (chemicals, venoms)
Normal Labs (RBCs, Hgb, Hct, MCV, MCH) - CORRECT ANSWER - RBCs 4.2-
6.1
Hgb 12-18
Hct 35-50%


MCV: 78-100 (related to size)
MCH: 27-34 (related to hgb content)


Reticulocytes: new RBC formation - low suggest issues in production
Microcytic-Hypochromic Anemias - CORRECT ANSWER - Characterized by
red cells that are abnormally small and contain reduced amounts of hemoglobin


Iron Deficiency Anemia (IDA)
Sideroblastic
Thalassemia
Iron Deficiency Anemia (IDA) - CORRECT ANSWER - Type of Microcytic-
Hypochromic Anemia


- Most common type of anemia
- Highest risk: older adults, women, infants, poverty


- Associated with cognitive impairment in children

Maak kennis met de verkoper

Seller avatar
De reputatie van een verkoper is gebaseerd op het aantal documenten dat iemand tegen betaling verkocht heeft en de beoordelingen die voor die items ontvangen zijn. Er zijn drie niveau’s te onderscheiden: brons, zilver en goud. Hoe beter de reputatie, hoe meer de kwaliteit van zijn of haar werk te vertrouwen is.
smartprof Walden University
Volgen Je moet ingelogd zijn om studenten of vakken te kunnen volgen
Verkocht
385
Lid sinds
3 jaar
Aantal volgers
311
Documenten
3279
Laatst verkocht
2 dagen geleden
Dr. Brains

Worried about upcoming exams? We’re here to make studying easier. Our comprehensive study materials are designed to sharpen your focus, boost your confidence, and help you step into your exams fully prepared. Compiled from real past papers, they offer valuable insight into common question types and effective answering techniques — so you can study efficiently and score higher. Why Choose Us? 5 star rated seller Trusted by over 350 student Reliable resources for healthcare and certification success Friendly support, always ready to help

Lees meer Lees minder
3,9

61 beoordelingen

5
25
4
19
3
8
2
2
1
7

Recent door jou bekeken

Waarom studenten kiezen voor Stuvia

Gemaakt door medestudenten, geverifieerd door reviews

Kwaliteit die je kunt vertrouwen: geschreven door studenten die slaagden en beoordeeld door anderen die dit document gebruikten.

Niet tevreden? Kies een ander document

Geen zorgen! Je kunt voor hetzelfde geld direct een ander document kiezen dat beter past bij wat je zoekt.

Betaal zoals je wilt, start meteen met leren

Geen abonnement, geen verplichtingen. Betaal zoals je gewend bent via iDeal of creditcard en download je PDF-document meteen.

Student with book image

“Gekocht, gedownload en geslaagd. Zo makkelijk kan het dus zijn.”

Alisha Student

Veelgestelde vragen